IL-7 Therapy Boosts Immune Response in Cancer Patients
Vendredi 04 Juillet 2008 - 12:47 - 6 mois, 1 semaine depuis
-
Cancérologie
-
Medscape cancérologie
Treatment with recombinant human interleukin-7 was shown to safely induce polyclonal T cell expansion, resulting in dramatic increases in T cell numbers, in patients with refractory cancer Medscape Medical News